Macbee Planet (7095) Q1 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2026 earnings summary
11 Sep, 2025Executive summary
Revenue for Q1 FY04/2026 increased 11% year-over-year to ¥12,780 million, but operating profit dropped 41% to ¥754 million and profit attributable to owners fell 38.7% to ¥505 million.
Growth in the Investment and Human Talent industries was offset by a decline in Lending & Card, partially covered by Medical industry gains.
The LTV Marketing segment saw revenue up 9.8% year-over-year, but segment profit declined 14.7% due to higher advertising costs for certain clients.
Progress made on mid-term business plan, including new vertical and retail media initiatives and acquisition of two new high-value clients.
The company maintained its full-year forecast, expecting revenue of ¥61,000 million and profit attributable to owners of ¥3,760 million.
Financial highlights
Revenue: ¥12,780 million in Q1 FY04/2026, up 11% year-over-year.
Operating profit: ¥754 million, down 41% year-over-year.
Gross profit for Q1 FY04/2026 was ¥2,082 million, down from ¥2,248 million year-over-year.
Basic earnings per share for Q1 was ¥36.45, down from ¥56.88 year-over-year (adjusted for a 4-for-1 stock split).
SG&A expenses increased, notably in personnel and advertising.
Outlook and guidance
Record-high revenue and operating profit expected from Q3 onward, driven by recovery in Lending & Card and Investment industries and expansion in Insurance clients.
Q2 revenue forecasted at approximately ¥13.5 billion and operating profit at ¥0.95 billion.
Full-year revenue is forecast at ¥61,000 million (up 18.0% year-over-year), with operating profit of ¥5,600 million (up 8.3%) and basic EPS of ¥270.99.
Full-year profit impact from corporate hometown tax expected to be minimal due to tax credits.
No changes have been made to previously announced forecasts.
Latest events from Macbee Planet
- Revenue and profit fell sharply year-over-year, but full-year guidance is maintained.7095
Q3 202613 Mar 2026 - Operating profit and margin fell as revenue growth slowed, leading to a downward forecast revision.7095
Q2 202611 Dec 2025 - Sales and profits more than doubled, with strong outlook and a 4-for-1 stock split ahead.7095
Q4 202424 Jul 2025 - Record sales and profit growth, led by medical and LTV Marketing, with a major share buyback.7095
Q1 202524 Jul 2025 - Sales up 30% in 1H, with strong growth in medical, finance, and LTV Marketing.7095
Q2 202524 Jul 2025 - Net sales and profits rose sharply, with upgraded guidance and strong LTV Marketing growth.7095
Q3 202524 Jul 2025 - Record sales and profit growth, with strong FY2026 outlook and expanded shareholder returns.7095
Q4 202524 Jul 2025